INmune Bio(INMB) - 2023 Q4 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Conference Call March 28, 2024 4:30 PM ET Company Participants RJ Tesi - Chief Executive Officer David Moss - Chief Financial Officer Mark Lowdell - Chief Scientific Officer Conference Call Participants Joel Beatty - Baird Daniel Carlson - Tailwinds Research Operator Ladies and gentlemen, greetings and welcome to the INmune Bio Fourth Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will ...